Commentary & Perspectives

What Dentistry Must Learn About Compounded Drugs

From GLP-1 medications to gum therapy, the surge in compounded drugs raises critical issues for patient safety and professional responsibility.

1

The rise of compounded semaglutide reflects safety and efficacy issues.
2

Compounded minocycline gels lack FDA approval and clinical data.
3

Arestin delivers medication for at least 14 days; compounded gels last 1-3 days.
4

Proper documentation is critical for prescribing compounded medications.
5

FDA regulations prohibit compounding identical copies of approved drugs without need.
6

Informed consent is essential to communicate risks of compounded products.
7

High standards of care must prioritize patient safety over untested alternatives.